Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1111/APHA.70051 | ||||
| Año | 2025 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
AimAmino acids, sugars, short-chain fatty acids (SCFA), vitamins, and other small molecules compose the extracellular metabolome on the airway lumen surface, but how the airway epithelium deals with these molecules has not been deeply studied. Due to the broad spectrum of metabolites transported by SLC5A8 and SLC5A12, we aim to determine if they are functionally expressed and participate in the absorption of Na+, short-chain fatty acids, and monocarboxylates in mouse and human airway epithelium.MethodsTracheas isolated from male or female mice and human bronchial epithelial cells (HBECs) were used for electrophysiological studies in the Ussing chamber and to detect members of the SLC16 family by RT-PCR and bulk RNAseq. Additionally, cell lines expressing the human and murine SLC5A8 transporter were employed for uptake studies using a fluorescent lactate probe.ResultsWe showed for the first time that human and murine airway epithelium express a functional SLC5A8 transporter, facilitating the absorption of glucose metabolites and SCFAs. The Na+-coupled monocarboxylate transport was not additive with ENaC-mediated Na+ absorption in mouse trachea. We observed that valproate acts as an inhibitor of the murine but not of the human SLC5A8 transporter.ConclusionsOur results demonstrate that several metabolites derived from bacterial and cellular metabolism can be transported from the airway lumen into the epithelial cells, participating in a homeostatic relation of the tissue with its environment.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Guequen, Anita | Mujer |
Centro de Estudios Científicos - Chile
Universidad Austral de Chile - Chile |
| 2 | Tapia-Balladares, Barbara | - |
Centro de Estudios Científicos - Chile
|
| 3 | Apablaza, Tabata | - |
Centro de Estudios Científicos - Chile
Universidad San Sebastián - Chile |
| 4 | Guidone, Daniela | - |
Telethon Inst Genet & Med TIGEM - Italia
TIGEM Telethon Institute of Genetics and Medicine - Italia |
| 5 | Carcamo-Lemus, Natali | - |
Centro de Estudios Científicos - Chile
|
| 6 | Villanueva, Sandra | Mujer |
Centro de Estudios Científicos - Chile
Universidad San Sebastián - Chile |
| 7 | Sandoval, Pamela Y. | - |
Centro de Estudios Científicos - Chile
Universidad San Sebastián - Chile |
| 8 | Galietta, Luis J. V. | Hombre |
Telethon Inst Genet & Med TIGEM - Italia
Univ Napoli Federico II - Italia TIGEM Telethon Institute of Genetics and Medicine - Italia Università Degli Studi di Napoli Federico II - Italia |
| 9 | FLORES-PIMILLA, CARLOS ALEJANDRO | Hombre |
Centro de Estudios Científicos - Chile
Universidad San Sebastián - Chile |
| Fuente |
|---|
| FONDECYT |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Fondecyt Regular |
| Fondazione per la Ricerca sulla Fibrosi Cistica |
| Universidad San Sebastin |
| Italian Foundation for Cystic Fibrosis Research (FFC Ricerca: FFC) |
| Fund for Folk Culture |
| Gallipoli Medical Research Foundation |
| Agradecimiento |
|---|
| This work was supported by FONDECYT Regular 1221257 (C.A.F.), FOVI 220118 (C.A.F.), FONDECYT postdoctoral 3220672 (S.V.), USS-FIN-23-FAPE-03 (P.Y.S.) and by the Italian Foundation for Cystic Fibrosis Research (FFC Ricerca: FFC#9/2022 and GMRF#1/2024) (L.J.V.G.). |
| Funding: This work was supported by FONDECYT Regular 1221257 (C.A.F.), FOVI 220118 (C.A.F.), FONDECYT postdoctoral 3220672 (S.V.), USS-FIN-23-FAPE-03 (P.Y.S.) and by the Italian Foundation for Cystic Fibrosis Research (FFC Ricerca: FFC#9/2022 and GMRF#1/2024) (L.J.V.G.). This work was supported by FONDECYT Regular 1221257 (C.A.F.), FOVI 220118 (C.A.F.), FONDECYT postdoctoral 3220672 (S.V.), USS-FIN-23-FAPE-03 (P.Y.S.) and by the Italian Foundation for Cystic Fibrosis Research (FFC Ricerca: FFC#9/2022 and GMRF#1/2024) (L.J.V.G.). |
| This work was supported by FONDECYT Regular 1221257 (C.A.F.), FOVI 220118 (C.A.F.), FONDECYT postdoctoral 3220672 (S.V.), USS\u2010FIN\u201023\u2010FAPE\u201003 (P.Y.S.) and by the Italian Foundation for Cystic Fibrosis Research (FFC Ricerca: FFC#9/2022 and GMRF#1/2024) (L.J.V.G.). Funding: |
| This work was supported by FONDECYT Regular 1221257 (C.A.F.), FOVI 220118 (C.A.F.), FONDECYT postdoctoral 3220672 (S.V.), USS\u2010FIN\u201023\u2010FAPE\u201003 (P.Y.S.) and by the Italian Foundation for Cystic Fibrosis Research (FFC Ricerca: FFC#9/2022 and GMRF#1/2024) (L.J.V.G.). |